In collaboration with PA Media Group

• Health & Medicine

Advanced ovarian cancer treatment approved for Cancer Drugs Fund

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund. A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

11 October 2019

• Health & Medicine

New batch of treatment decisions for NHS Scotland

The Scottish Medicines Consortium (SMC) has made decisions on five new cancer treatments, including a personalised blood cancer immunotherapy. The Scottish Medicines Consortium (SMC) has made decisions on five new cancer treatments, including a personalised blood cancer immunotherapy.

10 October 2019

• Health & Medicine

Immunotherapy for triple negative breast cancer gets initial ‘no’ for NHS in England

An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England. An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.

3 October 2019

• Health & Medicine

Two lung cancer drugs approved and one rejected for NHS Scotland

Two lung cancer drugs have been made available through NHS Scotland while another drug has been rejected. Two lung cancer drugs have been made available through NHS Scotland while another drug has been rejected.

16 September 2019

• Health & Medicine

CAR T cell immunotherapy now available through NHS Scotland for some adults with lymphoma

A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma. A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.

13 September 2019

• Health & Medicine

New treatment option for certain leukaemia patients in Scotland

A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland. A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.

14 August 2019

• Health & Medicine

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

9 August 2019

• Health & Medicine

Makeup of bacteria in pancreatic tumours linked to survival

US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live. US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live.

9 August 2019

• Health & Medicine

Lung cancer immunotherapy combo added to Cancer Drugs Fund

Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England. Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.

8 August 2019

• Health & Medicine

Daily aspirin reduces bowel cancer risk in people with Lynch syndrome, says NICE

Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE. Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE.

2 August 2019

• Health & Medicine

Ovarian cancer drug will be offered earlier to NHS patients in England

A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England. A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.

26 July 2019

• Health & Medicine

Second breast cancer treatment combo added to England's Cancer Drugs Fund

Some patients with advanced breast cancer will now have access to a new drug combo on the NHS in England – after the NICE reversed its initial decision Some patients with advanced breast cancer will now have access to a new drug combo on the NHS in England – after the NICE reversed its initial decision

17 July 2019